Medinno (Drug Discovery) Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$29.8M
- Investors
-
8
Medinno (Drug Discovery) General Information
Description
Developer of small-molecule therapeutics designed to address unmet treatment needs in chronic wounds, dermatological, and ophthalmic diseases. The company offers locally administered multi-target drug candidates engineered to act at affected tissues while limiting systemic exposure, enabling patients with inflammatory, autoimmune, and chronic wound conditions to access targeted treatments with improved safety profiles.
Contact Information
Corporate Office
- Unit 35, 3rd Floor, Building 9
- Number 129 Dingxing Road, Tangjiawan Town, High-tech Zone
- Zhuhai, Guangdong 519000
- China
Corporate Office
- Unit 35, 3rd Floor, Building 9
- Number 129 Dingxing Road, Tangjiawan Town, High-tech Zone
- Zhuhai, Guangdong 519000
- China
Medinno (Drug Discovery) Timeline
Medinno (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 16-Sep-2026 | $29.8M | Completed | Generating Revenue | ||
| 1. Later Stage VC | 15-Jan-2024 | Completed | Generating Revenue |
Medinno (Drug Discovery) Signals
Medinno (Drug Discovery) Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Insight Capital (Taicang) | Venture Capital | Minority | ||
| Laurel Venture Capital | Venture Capital | Minority | ||
| Sunshine Ronghui Capital Investment Management | Corporate Venture Capital | Minority | ||
| Xiamen C&D Corporation | Corporation | Minority | ||
| Xiamen Hi-Tech Innovation Center | Venture Capital | Minority |
Medinno (Drug Discovery) FAQs
-
When was Medinno (Drug Discovery) founded?
Medinno (Drug Discovery) was founded in 2017.
-
Where is Medinno (Drug Discovery) headquartered?
Medinno (Drug Discovery) is headquartered in Zhuhai, China.
-
What is the size of Medinno (Drug Discovery)?
Medinno (Drug Discovery) has 8 total employees.
-
What industry is Medinno (Drug Discovery) in?
Medinno (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Medinno (Drug Discovery) a private or public company?
Medinno (Drug Discovery) is a Private company.
-
What is Medinno (Drug Discovery)’s current revenue?
The current revenue for Medinno (Drug Discovery) is .
-
How much funding has Medinno (Drug Discovery) raised over time?
Medinno (Drug Discovery) has raised $29.8M.
-
Who are Medinno (Drug Discovery)’s investors?
Insight Capital (Taicang), Laurel Venture Capital, Sunshine Ronghui Capital Investment Management, Xiamen C&D Corporation, and Xiamen Hi-Tech Innovation Center are 5 of 8 investors who have invested in Medinno (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process